Table 1.
Patient | Histology/Pathology | Intervals of 5 min | Test-retest intervals | Outcome (ILAE) | Follow-up (months) | Morphology Detector prediction | Hardware SNN prediction |
---|---|---|---|---|---|---|---|
1 | HS | 28 | 0.95 | 1 | 12 | TN | TN |
2 | Glioma | 13 | 0.97 | 1 | 29 | TN | TN |
3 | HS | 39 | 0.83 | 1 | 13 | TN | TN |
4 | HS | 34 | 0.96 | 1 | 41 | TN | TN |
5 | HS | 35 | 0.91 | 1 | 14 | TN | TN |
6 | HS | 35 | 0.59 | 1 | 11 | TN | TN |
7 | HS | 1 | — | 3 | 42 | FN | FN |
8 | HS | 16 | 0.74 | 3 | 15 | FN | TP |
9 | HS | 12 | 0.90 | 5 | 46 | FN | FN |
HS hippocampal sclerosis; ILAE seizure outcome classification of the International League Against Epilepsy.